VERU INC. Operating Lease Right-of-Use Assets
VERU INC. (VERU) had Operating Lease Right-of-Use Assets of $2.34 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-10
- 2026-06-30: Operating Lease, Right-of-Use Asset $2.34M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $2.48M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $2.61M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $2.75M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $2.34M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $2.48M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $2.61M 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $2.75M 10-Q · filed 2026-08-10 | |
| 2025-06-30 | $2.88M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $3.00M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $3.13M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $3.25M 10-K · filed 2025-12-17 | $3.56M 10-K · filed 2024-12-16 |
| 2024-06-30 | $3.76M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $3.95M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $4.13M 10-Q · filed 2024-04-01 | |
| 2023-09-30 | $4.33M 10-K · filed 2024-12-16 | |
| 2023-06-30 | $4.50M 10-Q/A · filed 2023-11-15 | |
| 2023-03-31 | $4.68M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $4.60M 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $4.79M 10-K/A · filed 2024-04-01 | |
| 2022-06-30 | $4.97M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $5.13M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $869.02K 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $969.84K 10-K · filed 2022-12-05 | |
| 2021-06-30 | $1.07M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.17M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $1.26M 10-Q · filed 2021-02-10 | |
| 2020-09-30 | $1.35M 10-K · filed 2021-12-02 | |
| 2020-06-30 | $1.01M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $1.08M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $1.15M 10-Q · filed 2020-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |